Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma
Eur Urol
.
2017 Jan;71(1):79-80.
doi: 10.1016/j.eururo.2016.07.046.
Epub 2016 Jul 29.
Authors
Ninghan Feng
1
,
Yu Yin
2
,
Yiping He
3
,
Jiaoti Huang
4
Affiliations
1
Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, China; Wuxi Medical School, Jiangnan University, Wuxi, China.
2
Department of Pathology, Anhui Medical University, Hefei, China; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
3
Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
4
Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: jiaoti.huang@duke.edu.
PMID:
27481176
DOI:
10.1016/j.eururo.2016.07.046
No abstract available
Publication types
Editorial
Comment
MeSH terms
Alternative Splicing*
Carcinoma, Neuroendocrine
Carcinoma, Small Cell
Humans
Male
Prostatic Neoplasms*